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EDITORIAL COMMENT
Lone Atrial Fibrillation Ablation





Atrial fibrillation (AF) is the most frequent supraventricular
arrhythmia, and its therapy is still unsatisfactory. Different
theories have been proposed to explain its mechanism.
Nowadays it seems well accepted that both focal and
re-entrant mechanisms are involved, playing a different role
in the initiation and maintenance of the arrhythmia. More-
over, the importance of each mechanism varies in patients
with different etiologies of the arrhythmia. The presence of
atrial foci functioning as triggers, generally localized in the
pulmonary veins (PVs), is the main finding in patients with
lone or idiopathic AF. In this patient population, the focal
ablation of AF has been shown to be quite effective. In
contrast, in patients with chronic AF and valvular heart
disease associated with concomitant pathologic atrial mod-
ifications, the ablation of the atrial foci is less effective. It
seems reasonable to suppose that in patients with chronic
AF an abnormal substrate with short and nonhomogeneous
conduction properties plays a more important role than the
trigger foci.
See page 475
On the basis of these clinical results, in patients with
paroxysmal lone AF, transvenous catheter ablation of the
foci with the electrical isolation of PVs has been proposed as
first-line nonpharmacologic therapy. In contrast, in patients
with permanent AF and/or associated heart disease (espe-
cially valvulopathies with enlargement of the left atrium),
surgical linear lesions are generally performed with the aim
to modify the electrical substrate.
Kottkamp et al. (1) proposed a surgical linear approach in
patients with lone AF without any other indication for
cardiac surgery, and the risk/effectiveness ratio of this
minimally invasive surgical approach was evaluated.
Cox et al. (2) was the first to demonstrate the possibility
of a cure of AF by means of biatrial linear incisions (Maze
procedure). This procedure aims to reduce the electrical
critical mass and to create conduction barriers that prevent
the circulation of the re-entrant atrial wavelets. Although
quite effective, the Maze procedure is a very complex
operation requiring a long procedure time and is associated
with complications (2). For this reason, various limited
surgical and transcatheter techniques have been designed
that relate to the modification of the substrate rather than to
reduction of the critical mass.
In most surgical techniques the main objective is to create
limited linear lesions in the left atrium (3–6), although in
some cases isolation of the PVs becomes the principal aim
(7,8). These approaches have been attempted mostly in
patients with valvular heart disease and permanent or
paroxysmal AF. The success rate has varied from 60% to
90% depending on the type of the lesion scheme utilized
and the population studied. It is noteworthy that the
posterior sections of the left atrium and the ostia of PVs
were involved in all cases despite the different energy sources
used (radiofrequency [RF] or cryoenergy) and the different
design of the intended lesion. These results imply that the
posterior part of the left atrium is crucial in the genesis and
maintenance of AF. Atrial activation during AF is not
spatially homogeneous, and regions with more or less
disorganized activation usually coexist in the same patient
(9,10). The posterior left atrium represents a region with a
high degree of disorganized atrial activity and seems to be
critical in the maintenance of the re-entrant fibrillating
wavelets.
Reviewing the data from the clinical studies published, it
is still unclear which is the predominant effect of ablation. Is
the clinical success due to the modification of the substrate
by linear lesions or to the abolition of atrial foci inside the
PVs or both? The study by Kottkamp et al. (1) does not
completely clarify the issue. In fact, the ablation target was
the elimination of left atrial macro–re-entrant “anchor”
circuits utilizing linear lesions. However, the ablation probe
was inserted a few millimeters inside the PVs. As it is
known (11) that PVs may sometimes be electrically isolated
with only few RF deliveries, it is evident how much difficult
it is to claim the results are due to the “pure substrate
modification” or to elimination of the triggers to some
extent. Intra- or postoperative mapping assessing the pos-
sible presence of atrial foci inside PVs or their electrical
isolation would have been useful to clarify the issue. This is
particularly important because it has been shown that in this
type of population most of the patients present lone AF in
which the triggers usually play a more prominent role.
The work of Kottkamp et al. (1) examined a patient
population in which the only indication for surgery was AF
resistant to drug therapy. A minimally invasive surgical
technique was used in order to reduce the risks of the
surgical procedure. Surgery with video-assisted images al-
lows the surgeons to perform surgery on lesions in exact,
specific areas. It should prevent gaps of conduction in the
ablation lines owing to the good contact between the probe
and the atrial tissue, solving in such a way one of the most
difficult problems encountered with transvenous catheter
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ablation. However, even under direct vision, gaps were
present in at least three patients who needed RF ablation to
terminate atypical left atrial flutter.
As in previous surgical reports (3–8) the success rate is
quite high, and almost all the patients maintain stable sinus
rhythm after the ablation procedure. In some cases, how-
ever, drug therapy remains necessary. It is interesting to note
the difference between patients with paroxysmal and per-
manent AF in the clinical follow-up. The overall success
rate is similar between the two groups, but in the latter
group a higher number of patients still needed drug therapy
to maintain sinus rhythm. The drug-free patients were
about 55% in the permanent group and 83% in the parox-
ysmal group. This clinical evidence also supports the con-
cept that in patients with paroxysmal and permanent AF,
the mechanisms and the substrates underlying the arrhyth-
mia are probably different, as shown by endocardial atrial
activation mapping (10).
The success rate of this surgical approach (95%, with the
additional use of drugs in some cases) is higher than the
success rate reported with transvenous linear ablation lim-
ited to the right atrium (12,13) or performed in both atria
(13–15). However, these results are only slightly better in
terms of maintenance of sinus rhythm than what is de-
scribed in patients who underwent PV isolation (11,16).
This latter technique evolved over the last five years. At the
beginning, the aim was to localize the vein responsible for
the AF initiation, and the ablation was performed inside the
vein where the triggering foci were localized (17). With this
approach a high incidence of recurrences was reported
because of the presence of different foci in the other PVs.
More important, a high incidence of complications, such as
PV stenosis, was described. This was attributed either to the
amount of energy used or to the delivery of the energy inside
the vein. Today the technique has been modified: electrical
isolation of all four PVs is usually performed, and the RF
energy is generally delivered as much as possible proximally
to the ostium in order to reduce the risk of stenosis. The
electrical PV isolation can be accomplished either with a
mere anatomic approach (18,19) or with an electrically
guided approach (11). In the latter case the ablation is
limited to the vein section where the muscular strands
connect to the atrial myocardium. In such a way the
electrical isolation can be obtained with a fewer number of
RF deliveries, leading to a theoretical reduction of compli-
cations, especially PV stenosis, thus maintaining a high
success rate of about 85% (11).
Considering that at the present time in the patient
population considered (lone AF) the minimally invasive
surgical approach shows only a slight benefit over the
transvenous approach, the clinician should suggest the
treatment with the best risk/benefit ratio. With the surgical
technique proposed by Kottkamp et al. (1), the risks related
to sternotomy are not present. Moreover, cardiac tampon-
ade and PV stenosis have not been described. Still, the
procedure is not completely free of complications. In fact, 2
patients out of 70 suffered from major complications. One
patient developed symptomatic circumflex coronary artery
stenosis related to the use of RF energy in close proximity to
the course of the artery. A second patient had esophageal
perforation with septicemia. This complication is related to
the possible conduction of the heat generated by RF energy
outside the intended operative field and may have fatal
consequences as reported by other investigators (20).
The incidence of complications may be reduced either
with technical methods as suggested by the researchers or by
using a different energy source, such as cryoenergy. Cryoen-
ergy produces a lesion that generally preserves the integrity
of adjacent structures (particularly of the vessels) (21). In a
previous report (5) no damage of adjacent structures and
particularly of the esophagus was reported. In addition,
owing to the preservation of the collagen tissue, no risk of
perforation and consequent fistula is present, even in cases
of damage to adjacent structures.
In summary, the study by Kottkamp et al. (1) clearly
confirms how linear lesions in the posterior part of the left
atrium connecting the PVs and the mitral annulus are
effective in curing AF in most patients with or without
associated heart disease. The surgical approach, however, is
still ineffective in some patients, and in more than one-third
of patients with permanent AF, drug therapy is still neces-
sary to maintain sinus rhythm. Possible explanation may be
either the fact that the ablation lesions are not deployed in
the right areas or that the lesions are not transmural or are
incomplete. A postprocedure extensive electrophysiologic
evaluation confirming the completeness of the lines of
conduction block and its correlation with clinical results
may provide an answer to these questions. Despite its
complexity, this electrophysiologic mapping has been at-
tempted after transvenous catheter ablation, looking for
lines of double potentials (22) or of conduction block with
nonfluoroscopic navigation system (CARTO, Biosense
Webster) (14,15). At the present time no data are available
in patients who underwent surgical ablation of AF.
The presence of gaps along the lines of ablation has been
demonstrated in the patients who developed left atrial
atypical flutter (1). It can be hypothesized that in patients
who need antiarrhythmic drugs to prevent AF recurrences,
the ablation lines still present some conduction gaps or they
are not transmural.
The success rates of surgical and transvenous ablation are
similar even if it seems slightly in favor of surgery. However,
complications have been described in both cases. This must
be clearly kept in mind when choosing an approach. In fact,
the success rate and the morbidity and mortality of the
procedure and the morbidity and mortality associated with
the disease for which the treatment is proposed must be
carefully evaluated.
Finally, both the knowledge and the success rates of AF
ablation, surgical or percutaneous, have greatly improved
over the last decade, with a substantial reduction of the
complications related to the procedure. But these compli-
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cations still occur and are not trivial. Therefore, we should
conclude that today an optimal approach for AF ablation is
not yet available. In fact, considering the relative benign
nature of AF, the “optimal” ablation technique should
present not only a high success rate but, above all, a very low
risk of complications.
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